Essex Savings Bank Lowers Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Essex Savings Bank trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 7.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 950 shares of the company’s stock after selling 81 shares during the period. Essex Savings Bank’s holdings in HCA Healthcare were worth $257,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in HCA. Norges Bank acquired a new position in HCA Healthcare during the 4th quarter worth $547,104,000. Royal Bank of Canada grew its position in shares of HCA Healthcare by 102.0% during the second quarter. Royal Bank of Canada now owns 3,650,988 shares of the company’s stock worth $1,108,001,000 after buying an additional 1,843,887 shares in the last quarter. Morgan Stanley raised its holdings in HCA Healthcare by 51.5% in the fourth quarter. Morgan Stanley now owns 2,229,190 shares of the company’s stock valued at $534,917,000 after acquiring an additional 758,127 shares in the last quarter. MFN Partners Management LP increased its position in shares of HCA Healthcare by 102.9% in the 1st quarter. MFN Partners Management LP now owns 1,261,201 shares of the company’s stock valued at $316,081,000 after purchasing an additional 639,701 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in shares of HCA Healthcare by 14.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,800,847 shares of the company’s stock worth $701,948,000 after purchasing an additional 347,177 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.2 %

Shares of HCA Healthcare stock opened at $329.35 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.18 and a debt-to-equity ratio of 35.07. The company’s 50-day simple moving average is $313.78 and its 200-day simple moving average is $274.88. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $334.49. The firm has a market cap of $87.11 billion, a price-to-earnings ratio of 17.35, a price-to-earnings-growth ratio of 1.67 and a beta of 1.65.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, topping analysts’ consensus estimates of $5.05 by $0.85. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The firm had revenue of $17.30 billion for the quarter, compared to analyst estimates of $16.51 billion. During the same quarter in the prior year, the company posted $4.64 earnings per share. HCA Healthcare’s quarterly revenue was up 11.7% on a year-over-year basis. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 20.49 earnings per share for the current year.

HCA Healthcare announced that its board has initiated a share buyback plan on Tuesday, January 30th that permits the company to buyback $6.00 billion in shares. This buyback authorization permits the company to reacquire up to 7.4% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its shares are undervalued.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were paid a dividend of $0.66 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.60. The ex-dividend date was Thursday, March 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.80%. HCA Healthcare’s payout ratio is 13.91%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,200 shares of the firm’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total value of $981,728.00. Following the completion of the transaction, the executive vice president now owns 24,929 shares in the company, valued at $7,647,967.91. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, SVP Kathryn A. Torres sold 3,861 shares of HCA Healthcare stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the completion of the sale, the senior vice president now owns 15,899 shares in the company, valued at approximately $4,880,993. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 3,200 shares of HCA Healthcare stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total transaction of $981,728.00. Following the sale, the executive vice president now owns 24,929 shares of the company’s stock, valued at $7,647,967.91. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,840 shares of company stock valued at $4,588,869. 1.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have issued reports on HCA. Raymond James lifted their price target on HCA Healthcare from $300.00 to $330.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Truist Financial upped their target price on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Cantor Fitzgerald restated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a research note on Tuesday, March 5th. Finally, Royal Bank of Canada boosted their target price on HCA Healthcare from $308.00 to $322.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $311.47.

Get Our Latest Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.